Meeting The FDA's CAPA Expectations

Year after year, deficiencies in corrective and preventative action (CAPA) procedures have consistently topped the list of the most common observations during FDA inspections in the medical device industry.

To remain in compliance, avoid receiving a Form 483 citation, and ensure that your product remains safe on the market, it is essential for leadership teams in medical device companies to thoroughly understand CAPA and take proactive steps to meet the FDA's expectations.

At times, enlisting a third-party expert can be invaluable, especially when establishing and enhancing your CAPA procedures. If you are concerned about the current status or quality of your CAPA procedures or simply wish to deepen your understanding, download our white paper. It offers comprehensive insights and practical guidance on how to ensure your organization is CAPA-ready.